Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Invitae Corp (NVTA) USD0.0001

Sell:$33.29 Buy:$33.33 Change: $0.25 (0.76%)
Market closed |  Prices as at close on 5 August 2020 | Switch to live prices |
Sell:$33.29
Buy:$33.33
Change: $0.25 (0.76%)
Market closed |  Prices as at close on 5 August 2020 | Switch to live prices |
Sell:$33.29
Buy:$33.33
Change: $0.25 (0.76%)
Market closed |  Prices as at close on 5 August 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. As of December 31, 2016, the Company's products consisted of assays totaling over 1,100 genes that could be used for multiple indications, including hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders and other hereditary conditions. The Company offers panels for a range of hereditary conditions in cancer, cardiology, neuromuscular, pediatric and rare diseases. The Company focuses on genetic testing, genome network and genome management. The Company offers full gene sequencing and deletion/duplication analysis as a standard for all of its tests. The Company holds interests in AltaVoice, a patient-centered data company.

Contact details

Address:
1400 16th St
SAN FRANCISCO
94103-5110
United States
Telephone:
+1 (415) 3747782
Website:
https://www.invitae.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NVTA
ISIN:
US46185L1035
Market cap:
$4.14 billion
Shares in issue:
125.01 million
Sector:
Biotechnology
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Sean George
    Chairman of the Board, President, Chief Executive Officer, Co-Founder
  • Shelly Guyer
    Chief Financial Officer
  • Kenneth Knight
    Chief Operating Officer
  • Robert Werner
    Chief Accounting Officer
  • Thomas Brida
    General Counsel, Secretary
  • Robert Nussbaum
    Chief Medical Officer
  • Katherine Stueland
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.